1. Monoclonal antibodies and radioimmunoconjugates in the diagnosis and treatment of prostate cancer;Abdel-Nabi;Semin Urol,1992
2. Prognostic value of immunohistochemical staining for E-cadherin and a-catenin expression on prostate needle biopsies [abstract 959];Adenoro;J Urol,1996
3. Immunohistochemical determination of p53 protein accumulation in prostatic adenocarcinoma;Aprikian;J Urol,1994
4. Clinical and pathobiological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinoma;Armas;Am J Surg Pathol,1994
5. Preclinical results and human immunohistochemical studies with 90Y-CYT-356, a new prostatic cancer therapeutic agent [abstract];Axelrod;J Urol,1992